Health

Results: 5329-5340 of 5629

Business Wire logo

Mundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1

Business Wire logo

Medisca Takes Additional Steps to Protect Its Innovative Technologies

PR Newswire associated0

Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application

Business Wire logo

Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process

GlobeNewswire associated0

Tiziana Announces Positive Qualitative Six-Month PET Scan Results With Intranasal Foralumab Treating Multiple Sclerosis Patients Diagnosed With Non-Active Secondary Progressive MS (na-SPMS)

Copyrights - Sylvain Granjon

Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event

PR Newswire associated0

World Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwide

Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related Therapeutics

Business Wire logo

Meiji Seika Pharma Presents Positive Findings from Phase II Study of ME3183, Novel Highly-Potent Selective PDE4 Inhibitor, in Patients With Plaque Psoriasis at EADV Congress 2023

Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data

PR Newswire associated0

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion

EADV Congress: Study reveals significant stigma associated with female adult acne